<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Arthritis Res Ther</journal-id><journal-title>Arthritis Research &#x00026; Therapy</journal-title><issn pub-type="ppub">1478-6354</issn><issn pub-type="epub">1478-6362</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">ar2468</article-id><article-id pub-id-type="pmid">18681962</article-id><article-id pub-id-type="doi">10.1186/ar2468</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Caveolin-1 expression and stress-induced premature senescence in human intervertebral disc degeneration</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Heathfield</surname><given-names>Sarah Kathleen</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>Sarah.Heathfield@manchester.ac.uk</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Le Maitre</surname><given-names>Christine Lyn</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>C.Lemaitre@shu.ac.uk</email></contrib><contrib id="A3" corresp="yes" contrib-type="author"><name><surname>Hoyland</surname><given-names>Judith Alison</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>judith.a.hoyland@manchester.ac.uk</email></contrib></contrib-group><aff id="I1"><label>1</label>Tissue Injury and Repair Group, Research School of Clinical and Laboratory Sciences, Faculty of Medical and Human Sciences, Stopford Building, The University of Manchester, Oxford Road, Manchester, M13 9PT, UK</aff><aff id="I2"><label>2</label>Biomedical Research Centre, Biosciences, Faculty of Health and Wellbeing, Sheffield Hallam University, City Campus, Howard Street, Sheffield, S1 1WB, UK</aff><pub-date pub-type="ppub"><year>2008</year></pub-date><pub-date pub-type="epub"><day>5</day><month>8</month><year>2008</year></pub-date><volume>10</volume><issue>4</issue><fpage>R87</fpage><lpage>R87</lpage><ext-link ext-link-type="uri" xlink:href="http://arthritis-research.com/content/10/4/R87"/><history><date date-type="received"><day>20</day><month>5</month><year>2008</year></date><date date-type="rev-request"><day>12</day><month>6</month><year>2008</year></date><date date-type="rev-recd"><day>9</day><month>7</month><year>2008</year></date><date date-type="accepted"><day>5</day><month>8</month><year>2008</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2008 Heathfield et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2008</copyright-year><copyright-holder>Heathfield et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an open access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Heathfield Kathleen Sarah Sarah.Heathfield@manchester.ac.uk </dc:author><dc:title> Caveolin-1 expression and stress-induced premature senescence in human intervertebral disc degeneration </dc:title><dc:date>2008</dc:date><dcterms:bibliographicCitation>Arthritis Research &#x00026; Therapy 10(4): R87-. (2008)</dcterms:bibliographicCitation><dc:identifier type="sici">1478-6354(2008)10:4&#x0003c;R87&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1478-6354</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Introduction</title><p>Chronic and debilitating low back pain is a common condition and a huge economic burden. Many cases are attributed to age-related degeneration of the intervertebral disc (IVD); however, age-related degeneration appears to occur at an accelerated rate in some individuals. We have previously demonstrated biomarkers of cellular senescence within the human IVD and suggested a role for senescence in IVD degeneration. Senescence occurs with ageing but can also occur prematurely in response to stress. We hypothesised that stress-induced premature senescence (SIPS) occurs within the IVD and here we have investigated the expression and production of caveolin-1, a protein that has been shown previously to be upregulated in SIPS.</p></sec><sec sec-type="methods"><title>Methods</title><p>Caveolin-1 gene expression in human nucleus pulposus (NP) cells was assessed by conventional and quantitative real-time polymerase chain reaction (PCR), and caveolin-1 protein expression was examined within human IVDs using immunohistochemistry. The correlation between caveolin-1 and p16<sup>INK4a </sup>(biomarker of cellular senescence) gene expression was investigated using quantitative real-time PCR.</p></sec><sec><title>Results</title><p>Caveolin-1 gene expression and protein expression were demonstrated within the human IVD for the first time. NP cells from degenerate discs exhibited elevated levels of caveolin-1 which did not relate to increasing chronological age. A negative correlation was observed between gene expression for caveolin-1 and donor age, and no correlation was found between caveolin-1 protein expression and age. A positive correlation was identified between gene expression of caveolin-1 and p16<sup>INK4a</sup>.</p></sec><sec><title>Conclusion</title><p>Our findings are consistent with a role for caveolin-1 in degenerative rather than age-induced changes in the NP. Its expression in IVD tissue and its association with the senescent phenotype suggest that caveolin-1 and SIPS may play a prominent role in the pathogenesis of IVD degeneration.</p></sec></abstract></article-meta></front><body><sec><title>Introduction</title><p>Low back pain (LBP) is a condition that affects a significant proportion of the population, with a lifetime incidence rate in excess of 70% in industrialised nations [<xref ref-type="bibr" rid="B1">1</xref>]. It not only impacts on quality of life, but also places a substantial financial burden on the National Health Service and the economy in general due to loss of working days [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. Many cases of LBP are attributed to degeneration of the intervertebral disc (IVD) and imaging studies have indicated a link between IVD degeneration and LBP [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>].</p><p>To date, no clear mechanism for IVD degeneration has been identified, although the involvement of both environmental and genetic factors has been proposed [<xref ref-type="bibr" rid="B5">5</xref>-<xref ref-type="bibr" rid="B8">8</xref>]. The occurrence of IVD degeneration increases with age [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref>]; however, a subset of individuals appear to exhibit accelerated degeneration that is independent of age [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>]. This has led to speculation that additional factors could play a key role in the development of degeneration in some individuals.</p><p>There is increasing evidence that many features of IVD degeneration, including altered matrix synthesis and enhanced matrix degradation, originate at a cellular level [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>]. Cellular senescence is a strong candidate for the prolonged alteration in cellular activity observed during degeneration. Senescence and accompanying alterations in cell function have been implicated in ageing-related, degenerative, and pathological changes in a variety of tissues, including atherosclerotic plaque development within blood vessels and osteoarthritic alterations to cartilage [<xref ref-type="bibr" rid="B13">13</xref>-<xref ref-type="bibr" rid="B15">15</xref>]. Two groups have shown increased staining for senescence-associated &#x003b2;-galactosidase (SA-&#x003b2;-gal) in cells from prolapsed and degenerate IVD cells, respectively, when compared with non-degenerate discs [<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B17">17</xref>]. More recently, our group has presented more comprehensive evidence of senescence biomarkers in human IVD samples, demonstrating increased cellular senescence during IVD degeneration [<xref ref-type="bibr" rid="B18">18</xref>]. In particular, cells from degenerate discs exhibited increased SA-&#x003b2;-gal activity, elevated expression of the cell cycle inhibitor p16<sup>INK4a</sup>, telomere erosion, and a decrease in replicative potential. Furthermore, a correlation was observed between p16<sup>INK4a </sup>expression and the expression of matrix-degrading enzymes matrix metalloproteinase (MMP)-13 and a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)-5, suggesting a role for cell senescence in the molecular processes observed during IVD degeneration [<xref ref-type="bibr" rid="B18">18</xref>].</p><p>Senescence occurs naturally with ageing but can also occur prematurely in response to stresses (such as exposure to cytokines or oxidative stress) in a number of cell types [<xref ref-type="bibr" rid="B19">19</xref>-<xref ref-type="bibr" rid="B24">24</xref>]. Since telomeric erosion and p16<sup>INK4a </sup>protein expression are increased in degenerate discs compared to non-degenerate age-matched samples [<xref ref-type="bibr" rid="B18">18</xref>], we hypothesised that stress-induced premature senescence (SIPS) occurs within the IVD and may be responsible for the accelerated degeneration observed in some individuals.</p><p>Caveolae are plasma membrane compartments found abundantly in terminally differentiated cells such as fibroblasts and endothelial and muscle cells [<xref ref-type="bibr" rid="B25">25</xref>]. The mammalian caveolin gene family codes for three 21 to 25 kDa caveolin proteins, which are integral membrane proteins essential for the structural integrity and function of caveolae [<xref ref-type="bibr" rid="B26">26</xref>]. Expression of caveolin-3 is muscle-specific, whereas caveolin-1 and caveolin-2 are coexpressed in many cell types [<xref ref-type="bibr" rid="B26">26</xref>]. Proposed functions include lipid transport, membrane trafficking, and a role in intracellular signalling pathways which stems from the colocalisation of caveolins with a variety of signal transduction molecules [<xref ref-type="bibr" rid="B25">25</xref>-<xref ref-type="bibr" rid="B28">28</xref>]. Interestingly, caveolin-1 has been implicated in the senescent phenotype of several cell types, including human fibroblasts, lung adenocarcinoma cells, endothelial cells, and articular chondrocytes [<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B29">29</xref>-<xref ref-type="bibr" rid="B33">33</xref>]. Moreover, caveolin-1 has been proposed to mediate SIPS in murine fibroblasts and human articular chondrocytes in response to oxidative stress and the inflammatory cytokine interleukin-1&#x003b2; (IL-1&#x003b2;) (both of which are known to be increased during IVD degeneration) [<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B34">34</xref>-<xref ref-type="bibr" rid="B38">38</xref>]. Here, we have investigated the expression of caveolin-1 in human IVDs and correlated its expression with the cell cycle inhibitor and the biomarker of senescence p16<sup>INK4a</sup>, focusing on the nucleus pulposus (NP) as this area shows the most evidence of cell senescence in human IVDs [<xref ref-type="bibr" rid="B18">18</xref>].</p></sec><sec sec-type="materials|methods"><title>Materials and methods</title><sec><title>Tissue samples</title><p>Human IVD tissue was obtained either at post mortem (PM) examination or from patients undergoing surgery, where patients were selected on the basis of magnetic resonance imaging-diagnosed degeneration and progression to anterior resection either for spinal fusion or disc replacement surgery for chronic LBP. Local research ethics committee approval was obtained together with informed consent from the patient or relatives. Disc tissue was removed as detailed previously [<xref ref-type="bibr" rid="B37">37</xref>].</p><sec><title>General procedure for tissue specimens</title><p>A block of tissue (incorporating annulus fibrosus [AF] and NP in continuity) was fixed in 10% vol/vol neutral buffered formalin and embedded in paraffin wax. Four micron sections were stained with haematoxylin and eosin to grade the degree of morphological degeneration according to previously published criteria that assess the demarcation between NP and AF, proteoglycan content of the NP, presence and extent of structural fissures, and cell cluster formation [<xref ref-type="bibr" rid="B39">39</xref>]. Potential grades range between 0 and 12. A grade of 0 to 3 indicates a histologically non-degenerate IVD, 4 to 7 indicates evidence of intermediate (or moderate) degeneration, and 8 to 12 indicates severe degeneration. Further tissue sections were taken for immunohistochemical analysis of caveolin-1.</p></sec></sec><sec><title>Isolation of nucleus pulposus cells</title><p>To obtain NP cells from human IVD tissue, NP tissue was identified and dissected from AF. NP tissue was finely chopped and digested in a solution of 2 U/mL protease (Sigma-Aldrich, Gillingham, UK) in Dulbecco's modified Eagle's medium plus Ham's F-12 nutrient medium (DMEM + F-12) (Gibco BRL, now part of Invitrogen, Paisley, UK) for 30 minutes at 37&#x000b0;C. NP cells were washed twice with DMEM + F-12 prior to cell isolation with collagenase type I treatment (0.4 mg/mL; Invitrogen).</p></sec><sec><title>Conventional reverse transcription-polymerase chain reaction</title><p>To investigate gene expression of caveolin-1 in human NP cells, RNA was extracted from isolated cells following the standard procedure for TRIzol<sup>&#x000ae; </sup>reagent (Invitrogen). cDNA was then synthesised using Superscript II in accordance with the instructions of the manufacturer (Invitrogen). A standard Platinum Taq (Invitrogen) method was used for conventional polymerase chain reaction (PCR), using a concentration of 1.5 mM MgCl<sub>2</sub>. Primers specific for caveolin-1 [<xref ref-type="bibr" rid="B19">19</xref>] and the housekeeping gene <italic>18S </italic>(Invitrogen) are detailed in Table <xref ref-type="table" rid="T1">1</xref>. All primers were confirmed for gene specificity using BLAST (Basic Local Alignment Search Tool) (Genbank database sequences). Reactions, including non-template controls, were conducted for 35 cycles, including the annealing temperature of 58&#x000b0;C on a thermal cycler (MJ Research, now part of Bio-Rad Laboratories, Hercules, CA, USA), and products were analysed alongside a 100-base pair DNA ladder (Hyperladder IV; Bioline, London, UK) by electrophoresis on a 1.5% wt/vol agarose gel containing 0.2 &#x003bc;g/mL ethidium bromide (Sigma-Aldrich). Product bands were visualised by UV transillumination and images were captured using Gene Snap software (Syngene, Cambridge, UK).</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Details of polymerase chain reaction (PCR) primers, probes, and amplicon sizes</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left" colspan="4">Conventional PCR conditions</td></tr></thead><tbody><tr><td align="left">Target</td><td align="left">Forward primer 5' to 3'</td><td align="left">Reverse primer 5' to 3'</td><td align="left">Amplicon size, base pairs (bp)</td></tr><tr><td align="left"><italic>18S</italic></td><td align="left">GCC ATG CAT GTC TAA GTA CG</td><td align="left">GCT GGC ACC AGA CTT GCC</td><td align="left">574 bp</td></tr><tr><td align="left">Caveolin-1</td><td align="left">AAG GAG ATC GAC CTG G</td><td align="left">GGA ATA GAC ACG GCT G</td><td align="left">309 bp</td></tr><tr><td colspan="4"><hr></hr></td></tr><tr><td align="left" colspan="4">Real-time PCR primers and probes</td></tr><tr><td colspan="4"><hr></hr></td></tr><tr><td align="left">Target</td><td align="left">Forward primer 5' to 3'</td><td align="left">Probe 5' to 3'</td><td align="left">Reverse primer 5' to 3'</td></tr><tr><td align="left"><italic>18S</italic></td><td align="left">PDAR</td><td align="left">PDAR (VIC-TAMRA)</td><td align="left">PDAR</td></tr><tr><td align="left">Caveolin-1</td><td align="left">ACT TGC AAC CGT CTG TTA TGC T</td><td align="left">FAM &#x02013; ACA TGG CCC CTC CCC &#x02013; MGB</td><td align="left">GCA AAG GGA TGC TTG GAT TAG GT</td></tr><tr><td align="left">p16<sup>INK4a</sup></td><td align="left">GGC TCT ACA CAA GCT TCC TTT CC</td><td align="left">FAM &#x02013; ACC CTG GCT CTG ACC A &#x02013; MGB</td><td align="left">TCA TGA CCT GCC AGA GAG AAC A</td></tr></tbody></table><table-wrap-foot><p>PDAR, pre-developed assay reagent.</p></table-wrap-foot></table-wrap></sec><sec><title>Quantitative real-time polymerase chain reaction</title><p>Quantitative real-time reverse transcription-PCR (qRT-PCR) was performed to further examine caveolin-1 gene expression in human NP cells and to investigate any correlation between caveolin-1 and p16<sup>INK4a </sup>gene expression in isolated NP cells using the standard curve method of analysis as described previously [<xref ref-type="bibr" rid="B18">18</xref>].</p><sec><title>Primers and probe design</title><p>Primers and FAM-MGB probe specific for human caveolin-1 were designed by Applied Biosystems (ABI) (Warrington, UK) upon provision of caveolin-1-specific exon sequence (Gene expression assays) (Table <xref ref-type="table" rid="T1">1</xref>). p16<sup>INK4a </sup>primers and probe were as described previously [<xref ref-type="bibr" rid="B18">18</xref>], and <italic>18S </italic>primer/VIC-TAMRA probe set was a pre-developed assay reagent (PDAR) purchased from ABI.</p></sec><sec><title>Genomic curve standards</title><p>Genomic DNA (gDNA) was used to create standard curves for absolute quantification of copy number per reaction. gDNA (Promega Corporation, Southampton, UK) was homogenised, diluted to 100 ng/&#x003bc;L, and sonicated on ice. Serial dilutions of gDNA were prepared to generate standards with gene copy numbers of 75,000, 7,500, 750, 75, and 0 copies per 25 &#x003bc;L reaction.</p></sec><sec><title>Quantitative real-time reverse transcription-polymerase chain reaction amplification</title><p>qRT-PCRs were carried out in triplicate in a 96-well plate. Reactions contained 12.5 &#x003bc;L of mastermix (Taqman<sup>&#x000ae; </sup>Universal PCR mastermix; ABI) and 2.5 &#x003bc;L of template cDNA or gDNA. Primers were added to a final concentration of 900 nM and probe to a concentration of 250 nM, and molecular-grade water was added to a total reaction volume of 25 &#x003bc;L. A gDNA standard curve for each gene was included on each plate. Real-time PCR was performed using an ABI Prism 7000 sequence detection system (ABI). Reactions consisted of an initial Taq activation step of 95&#x000b0;C for 10 minutes to denature DNA and activate Taq polymerase followed by 40 cycles of 95&#x000b0;C for 15 seconds and 60&#x000b0;C for 1 minute.</p></sec><sec><title>Quantitative real-time reverse transcription-polymerase chain reaction analysis</title><p>Following amplification, an auto-baseline was set using the ABI 7000 sequence detection software and a threshold was set for each gene, above background levels and within the exponential phase. From these, a cycle threshold (Ct) was obtained for each well and data exported into Microsoft Excel (Microsoft Corporation, Redmond, WA, USA), where the three Ct values for each sample were averaged. Data were analysed as described previously [<xref ref-type="bibr" rid="B18">18</xref>] and results were expressed as copy number of target gene per 100 ng cDNA normalised to <italic>18S</italic>.</p></sec></sec><sec><title>Immunohistochemistry</title><p>Immunohistochemistry (IHC) was used to determine the expression and localisation of caveolin-1 protein in the NP of 28 paraffin-embedded disc samples (Table <xref ref-type="table" rid="T2">2</xref>). Normal human skin tissue was used as a positive control. The protocol was based upon previously published IHC [<xref ref-type="bibr" rid="B40">40</xref>]. Briefly, following deparaffination, blocking of endogenous peroxidase activity, and enzyme retrieval in 0.01% wt/vol chymotrypsin (Sigma-Aldrich) solution at 37&#x000b0;C for 20 minutes, sections were washed and incubated with 25% rabbit serum (Sigma-Aldrich) to block non-specific binding sites. Sections were then incubated at 4&#x000b0;C overnight with mouse monoclonal antibody against human caveolin-1 (BD Transduction Laboratories catalogue number 610406, clone 2297; BD Biosciences, Oxford, UK) (1:10 dilution in 25% rabbit serum in 0.1% bovine serum albumin; Sigma-Aldrich). Negative control sections were incubated with an equivalent concentration of mouse IgG1 (Dako UK Ltd., Ely, UK). Following washes in Tris-buffered saline (TBS), sections were incubated with biotinylated rabbit anti-mouse antiserum (1:400; Dako UK Ltd.) for 30 minutes at room temperature. After further washes in TBS, immunoreactivity was visualised using the streptavidin-biotin complex (Dako UK Ltd.) technique with 3,3'-diaminobenzidine tetrahydrochloride solution (Sigma-Aldrich). Sections were subsequently rinsed in water, counterstained with Mayer's haematoxylin, dehydrated, and mounted with Pertex (HistoLab, Gothenburg, Sweden).</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Details of human nucleus pulposus samples used to study caveolin-1 protein expression by immunohistochemistry</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center">Laboratory number</td><td align="center">Histological grade</td><td align="center">Age, years</td><td align="center">Source</td></tr></thead><tbody><tr><td align="center">1</td><td align="center">1</td><td align="center">25</td><td align="center">Surgery</td></tr><tr><td align="center">2</td><td align="center">1</td><td align="center">30</td><td align="center">PM</td></tr><tr><td align="center">3</td><td align="center">1</td><td align="center">47</td><td align="center">PM</td></tr><tr><td align="center">4</td><td align="center">2</td><td align="center">47</td><td align="center">PM</td></tr><tr><td align="center">5</td><td align="center">2</td><td align="center">75</td><td align="center">PM</td></tr><tr><td align="center">6</td><td align="center">2</td><td align="center">Unknown</td><td align="center">PM</td></tr><tr><td align="center">7</td><td align="center">3</td><td align="center">30</td><td align="center">PM</td></tr><tr><td align="center">8</td><td align="center">3</td><td align="center">30</td><td align="center">PM</td></tr><tr><td align="center">9</td><td align="center">3</td><td align="center">37</td><td align="center">PM</td></tr><tr><td align="center">10</td><td align="center">3</td><td align="center">74</td><td align="center">PM</td></tr><tr><td align="center">11</td><td align="center">4</td><td align="center">30</td><td align="center">PM</td></tr><tr><td align="center">12</td><td align="center">4</td><td align="center">37</td><td align="center">PM</td></tr><tr><td align="center">13</td><td align="center">5</td><td align="center">30</td><td align="center">PM</td></tr><tr><td align="center">14</td><td align="center">5</td><td align="center">74</td><td align="center">PM</td></tr><tr><td align="center">15</td><td align="center">5</td><td align="center">Unknown</td><td align="center">PM</td></tr><tr><td align="center">16</td><td align="center">5</td><td align="center">Unknown</td><td align="center">PM</td></tr><tr><td align="center">17</td><td align="center">6</td><td align="center">74</td><td align="center">PM</td></tr><tr><td align="center">18</td><td align="center">6</td><td align="center">75</td><td align="center">PM</td></tr><tr><td align="center">19</td><td align="center">7</td><td align="center">75</td><td align="center">PM</td></tr><tr><td align="center">20</td><td align="center">7</td><td align="center">78</td><td align="center">PM</td></tr><tr><td align="center">21</td><td align="center">8</td><td align="center">58</td><td align="center">PM</td></tr><tr><td align="center">22</td><td align="center">8</td><td align="center">75</td><td align="center">PM</td></tr><tr><td align="center">23</td><td align="center">9</td><td align="center">58</td><td align="center">PM</td></tr><tr><td align="center">24</td><td align="center">9</td><td align="center">74</td><td align="center">PM</td></tr><tr><td align="center">25</td><td align="center">9</td><td align="center">74</td><td align="center">PM</td></tr><tr><td align="center">26</td><td align="center">10</td><td align="center">58</td><td align="center">PM</td></tr><tr><td align="center">27</td><td align="center">11</td><td align="center">46</td><td align="center">Surgery</td></tr><tr><td align="center">28</td><td align="center">12</td><td align="center">Unknown</td><td align="center">PM</td></tr></tbody></table><table-wrap-foot><p>PM, post mortem tissue.</p></table-wrap-foot></table-wrap><p>Sections were visualised using a Leica RMDB microscope (Leica Camera Limited, Knowlhill, Milton Keynes, UK), and images were captured using a digital camera and Bioquant Nova image analysis system (Bioquant Image Analysis Corporation, Nashville, TN, USA). For analysis, the NP was identified morphologically within each disc section. Within each section, a minimum of 200 NP cells were analysed from at least five different fields of view and immunopositivity was calculated as a percentage of the total cell population.</p></sec><sec><title>Statistical analysis</title><p>Data were non-parametric and thus Mann-Whitney <italic>U </italic>tests were conducted to compare gene copy number and numbers of caveolin-1-immunopositive cells in non-degenerate NP (grades 0 to 3) and degenerate NP (grades 4 to 7 and 8 to 12). Non-parametric linear regression analysis was performed to analyse the correlation between copy numbers of different genes and between gene copy numbers and subject age or number of caveolin-1-immunopositive cells and subject age.</p></sec></sec><sec><title>Results</title><sec><title>Caveolin-1 gene expression in human nucleus pulposus cells</title><p>cDNAs derived from cells directly extracted from the NP of 19 different IVDs, from both PM and surgical sources, were analysed for expression of the caveolin-1 gene. Eight samples were taken from non-degenerate IVD (grades 0 to 3; mean age &#x000b1; standard deviation [SD] 45.4 &#x000b1; 18.7 years) and 11 samples from degenerate IVD (grades 4 to 9; 51.7 &#x000b1; 24.3 years). Gene expression for caveolin-1 was detected in the NP tissue of every sample analysed (qRT-PCR analysis). Comparison of caveolin-1 gene expression by non-degenerate and degenerate samples demonstrated higher gene expression in degenerate samples (conventional RT-PCR analysis, Figure <xref ref-type="fig" rid="F1">1</xref>). This was supported by qRT-PCR analysis (Figure <xref ref-type="fig" rid="F2">2a</xref>) in that non-degenerate samples demonstrated a median caveolin-1 gene copy number of 35,220 with a range of 6,740 to 70,9222 copies per 100 ng cDNA compared with the elevated degenerate median caveolin-1 gene copy number of 45,695 with a range of 7,589 to 105,626 copies per 100 ng cDNA (Figure <xref ref-type="fig" rid="F2">2a</xref>). A negative correlation was observed between gene expression for caveolin-1 and age of the donor (<italic>P </italic>= 0.0472) (Figure <xref ref-type="fig" rid="F2">2b</xref>).</p><fig position="float" id="F1"><label>Figure 1</label><caption><p>Conventional reverse transcription-polymerase chain reaction (RT-PCR) for caveolin-1 and housekeeping gene <italic>18S</italic>. Representative photographs following agarose gel electrophoresis of products from conventional RT-PCR for caveolin-1 and <italic>18S</italic>. cDNA samples displayed are non-degenerate samples from a post mortem (PM) source (respective grades [G] and ages of subjects: G3, 30 years; G1, 30 years; and G2, 75 years) and degenerate samples from surgical and PM sources (G5, 29 years; G6, 34 years; and G9, 74 years). Photographs are inverted to improve visualisation of product bands. Cav-1, caveolin-1.</p></caption><graphic xlink:href="ar2468-1"/></fig><fig position="float" id="F2"><label>Figure 2</label><caption><p>Quantitative real-time reverse transcription-polymerase chain reaction analysis of caveolin-1 gene expression levels in nucleus pulposus (NP) cells from human intervertebral disc. <bold>(a) </bold>Caveolin-1 gene expression per 100 ng cDNA normalised to <italic>18S </italic>in non-degenerate and degenerate NP presented as box-and-whisker plot (5&#x02013;95 percentile). <bold>(b) </bold>Correlation of caveolin-1 gene expression with age of subject. Non-parametric linear regression analysis (<italic>P </italic>= 0.0472; <italic>R</italic><sup>2 </sup>= 0.2122).</p></caption><graphic xlink:href="ar2468-2"/></fig></sec><sec><title>Immunohistochemical detection of caveolin-1 protein in human nucleus pulposus</title><p>Caveolin-1 protein expression was investigated in 28 IVD samples (for sample details, see Table <xref ref-type="table" rid="T2">2</xref>). Immunohistochemical analysis for caveolin-1 demonstrated cytoplasmic/membrane staining within the chondrocyte-like cells of the NP (Figure <xref ref-type="fig" rid="F3">3</xref>). The percentage of immunopositive cells for caveolin-1 increased from 2.59% &#x000b1; 1.01% (mean &#x000b1; standard error of the mean [SEM]) in non-degenerate discs to 13.62% &#x000b1; 6.51% in severely degenerate samples (Figure <xref ref-type="fig" rid="F4">4a</xref>). All IgG1 controls were negative. It must be noted that the majority of patients with severely degenerate discs were above 50 years of age; however, in the 24 samples of all grades for which the chronological age of individuals was known, no correlation was observed between caveolin-1 immunopositivity and age of the donors (<italic>P </italic>= 0.6609) (Figure <xref ref-type="fig" rid="F4">4b</xref>).</p><fig position="float" id="F3"><label>Figure 3</label><caption><p>Caveolin-1 immunohistochemistry. <bold>(a) </bold>Photomicrograph demonstrating staining for caveolin-1 protein in degenerate human nucleus pulposus (sample 28). <bold>(b) </bold>Immunoglobulin G controls were negative.</p></caption><graphic xlink:href="ar2468-3"/></fig><fig position="float" id="F4"><label>Figure 4</label><caption><p>Analysis of caveolin-1 immunohistochemistry. <bold>(a) </bold>Percentage of cells immunopositive for caveolin-1 protein in non-degenerate, moderately degenerate, and severely degenerate intervertebral discs. Data are shown as mean &#x000b1; SEM. <bold>(b) </bold>Correlation of caveolin-1 protein expression with age of subject. Non-parametric linear regression analysis (<italic>P </italic>= 0.6609; <italic>R</italic><sup>2 </sup>= 0.0089).</p></caption><graphic xlink:href="ar2468-4"/></fig></sec><sec><title>Correlation between caveolin-1 gene expression and gene expression of the senescence biomarker p16<sup>INK4a</sup></title><p>Seventeen NP samples were analysed for both caveolin-1 and p16<sup>INK4a </sup>gene expression using qRT-PCR. Analysis of p16<sup>INK4a </sup>expression agreed with our previous study [<xref ref-type="bibr" rid="B18">18</xref>] in that a higher proportion of degenerate than non-degenerate discs expressed p16<sup>INK4a</sup>. Of the five non-degenerate samples (from PM source, mean age &#x000b1; SD 45.8 &#x000b1; 18.4 years), only two samples expressed p16<sup>INK4a </sup>at copy numbers of 1.4 and 55.8 copies per 100 ng cDNA from individuals of 30 and 75 years of age, respectively. Eleven of the 12 degenerate samples (from both PM and surgical sources, 35.4 &#x000b1; 12.7 years) expressed p16<sup>INK4a </sup>with median and maximum copy numbers of 32.5 and 17,075 copies per 100 ng cDNA, respectively. qRT-PCR analysis demonstrated a significant correlation between caveolin-1 and p16<sup>INK4a </sup>gene expression in the degenerate NP samples (<italic>P </italic>= 0.02) (Figure <xref ref-type="fig" rid="F5">5</xref>).</p><fig position="float" id="F5"><label>Figure 5</label><caption><p>Correlation between caveolin-1 and p16<sup>INK4a </sup>gene expression in degenerate nucleus pulposus samples. Caveolin-1 and p16<sup>INK4a </sup>gene expression (copy number per 100 ng cDNA normalised to <italic>18S</italic>) analysed by quantitative real-time reverse transcription-polymerase chain reaction. Non-parametric linear regression analysis (<italic>P </italic>= 0.02; <italic>R</italic><sup>2 </sup>= 0.4725).</p></caption><graphic xlink:href="ar2468-5"/></fig></sec></sec><sec><title>Discussion</title><p>This study has demonstrated for the first time that cells from the NP of human IVDs express caveolin-1 and furthermore that caveolin-1 gene expression and protein expression are elevated in degenerate IVDs, but that this rise in caveolin-1 expression does not correlate with increasing age. This is consistent with a role for caveolin-1 in degenerative rather than age-induced changes in the NP.</p><p>Changes associated with tissue ageing and degeneration have been postulated to involve cellular senescence [<xref ref-type="bibr" rid="B41">41</xref>-<xref ref-type="bibr" rid="B43">43</xref>]. Two major categories of senescence are generally described in the literature as replicative senescence (RS) and SIPS. RS was first described by Hayflick in 1965 [<xref ref-type="bibr" rid="B44">44</xref>] and is widely regarded as one of the main mechanisms underlying the normal ageing process via reduction of telomere length to critical levels following cumulative population doublings. In addition, there are a number of reports describing premature induction of senescence as a result of cellular exposure to stress. Factors linked to the induction of SIPS vary widely, from DNA damage &#x02013; for example, radiation (bovine aortic endothelial cells [<xref ref-type="bibr" rid="B45">45</xref>]), UV light (human fibroblasts [<xref ref-type="bibr" rid="B46">46</xref>] and human melanocytes [<xref ref-type="bibr" rid="B47">47</xref>]), chemical treatment (nasopharyngeal carcinoma cells [<xref ref-type="bibr" rid="B48">48</xref>] and human fibroblasts [<xref ref-type="bibr" rid="B49">49</xref>,<xref ref-type="bibr" rid="B50">50</xref>]), and oxidative stress (human fibroblasts [<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B24">24</xref>] and human articular chondrocytes [<xref ref-type="bibr" rid="B19">19</xref>]) &#x02013; to oncogenic protein overexpression (for example, ras in human fibroblasts [<xref ref-type="bibr" rid="B51">51</xref>]) and exposure to inflammatory cytokines such as IL-1 and tumour necrosis factor-&#x003b1; (human chondrocytes and fibroblasts [<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B23">23</xref>]). Previous data from our laboratory described accelerated senescence (characterised by a variety of biomarkers, including reduced cell replication potential, elevated levels of the cell cycle inhibitor p16<sup>INK4a</sup>, increased SA-&#x003b2;-gal activity, and telomere erosion) in degenerate human IVDs compared with age-matched non-degenerate discs [<xref ref-type="bibr" rid="B18">18</xref>], suggesting that SIPS may be involved in IVD degeneration.</p><p>Caveolin-1 forms homodimers, or heterodimers with its family member caveolin-2, that insert into the plasma membrane of terminally differentiated cells [<xref ref-type="bibr" rid="B25">25</xref>]. The caveolin-1-rich areas termed caveolae and the caveolin proteins themselves are proposed to regulate cellular processes, including membrane traffic, signal transduction, and cellular senescence [<xref ref-type="bibr" rid="B25">25</xref>-<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B52">52</xref>]. Caveolin-1 was investigated here due to its possible role in cellular senescence, in particular SIPS [<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B52">52</xref>]. Here, we show that caveolin-1 gene expression and protein expression are increased during IVD degeneration, but not in a manner that is associated with increasing chronological age.</p><p>Moreover, we demonstrate a correlation between caveolin-1 and p16<sup>INK4a </sup>gene expression. p16<sup>INK4a </sup>is a cyclin-dependent kinase inhibitor that prevents retinoblastoma phosphorylation and arrests the cell cycle in the G<sub>0</sub>/G<sub>1 </sub>phase prior to entry into the synthesis phase [<xref ref-type="bibr" rid="B53">53</xref>,<xref ref-type="bibr" rid="B54">54</xref>]. Many studies have shown increased levels of p16<sup>INK4a </sup>alongside the occurrence and maintenance of permanent growth arrest and senescence, including a rodent model of ageing [<xref ref-type="bibr" rid="B55">55</xref>-<xref ref-type="bibr" rid="B57">57</xref>]. Previous studies by our group and others strongly suggest a role for p16<sup>INK4a </sup>in cellular senescence within degenerate tissue when compared with age-matched controls [<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B58">58</xref>]. Furthermore, elevated p16<sup>INK4a </sup>expression has been described in the premature senescence of human fibroblasts and leukaemic cells exposed to oncogenic ras and DNA double-strand breaks [<xref ref-type="bibr" rid="B51">51</xref>,<xref ref-type="bibr" rid="B59">59</xref>,<xref ref-type="bibr" rid="B60">60</xref>], strengthening the reports that p16<sup>INK4a </sup>is a biological marker for senescence. The present study demonstrated that the increased expression of caveolin-1 seen in the degenerate NP positively correlated with gene expression for p16<sup>INK4a</sup>, suggesting that caveolin-1 expression is linked to the senescent phenotype observed in these cells.</p><p>The literature describes evidence linking cell exposure to stressful stimuli to both caveolin-1 expression and cellular senescence. In mouse NIH 3T3 fibroblasts, administration of subcytotoxic levels of H<sub>2</sub>O<sub>2 </sub>to experimentally mimic oxidative stress induced cellular senescence and increased caveolin-1 expression. Treatment with H<sub>2</sub>O<sub>2 </sub>in the presence of caveolin-1 antisense oligonucleotides reduced expression of senescence biomarkers, whereas transgenic overexpression of caveolin-1 induced SIPS [<xref ref-type="bibr" rid="B31">31</xref>]. In human endothelial cells, isolated from atherosclerotic patients and induced to senesce, caveolin-1 expression was correlated with senescence biomarkers and with expression of 4-hydroxynonenal expression (a marker of lipid peroxidation and thus oxidative stress) independently of an effect on telomere length [<xref ref-type="bibr" rid="B31">31</xref>]. These studies strongly support a role for caveolin-1 in SIPS induced by oxidative stress and this is further strengthened by work conducted on osteoarthritic articular chondrocytes. Administration of H<sub>2</sub>O<sub>2 </sub>to these chondrocytes induced cellular senescence via expression of the caveolin-1 protein, a mechanism reversed by antisense oligonucleotide-mediated downregulation of the caveolin-1 gene [<xref ref-type="bibr" rid="B19">19</xref>]. The same study demonstrated an identical role for the inflammatory cytokine IL-1&#x003b2;.</p><p>Articular chondrocytes and the degenerative process observed during osteoarthritis share many characteristics with IVD cells and IVD degeneration [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B43">43</xref>]. Interestingly, IVD cells are subjected to both oxidative stress and catabolic cytokines, which have been implicated in the induction of SIPS [<xref ref-type="bibr" rid="B19">19</xref>-<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B24">24</xref>]. Work published by our group suggests that IL-1&#x003b2; not only is increased in degenerate discs but is an important factor involved in catabolic events during IVD degeneration, including decreased matrix production and increased MMP and ADAMTS expression [<xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B38">38</xref>,<xref ref-type="bibr" rid="B61">61</xref>,<xref ref-type="bibr" rid="B62">62</xref>]. Moreover, advanced glycation endproducts (AGEs) such as carboxymethyl-lysine (CML) and the receptor for AGEs (RAGE) have been localised to the NP of degenerate IVD [<xref ref-type="bibr" rid="B34">34</xref>-<xref ref-type="bibr" rid="B36">36</xref>]. CML is a tissue marker for accumulated oxidative stress [<xref ref-type="bibr" rid="B35">35</xref>]; therefore, its presence and that of its receptor RAGE are highly significant for both mechanisms underlying IVD degeneration and the likelihood that they could cause SIPS in human NP cells. Furthermore, RAGE has been localised to caveolin-1-rich membranes in endothelial cells [<xref ref-type="bibr" rid="B63">63</xref>]. This gives evidence, together with studies involving IL-1, that there are factors in the degenerate disc that may induce caveolin-1 expression and thus lead to the senescent phenotype described in IVD cells [<xref ref-type="bibr" rid="B16">16</xref>-<xref ref-type="bibr" rid="B18">18</xref>].</p><p>Caveolin-1-rich regions of the plasma membrane have been associated with several receptors and signalling molecules, predominantly through isolation of caveolae and colocalisation studies. These studies have highlighted a subset of proteins that are relevant to IVD degeneration and to SIPS. First, RAGE, described above, is known to regulate several intracellular signalling pathways, including the nuclear factor-kappa-B pathway, which is essential for the expression of MMPs present in the degenerate IVD [<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B64">64</xref>]. Second, there is evidence suggesting that caveolin-1, &#x003b2;1 integrin, and urokinase plasminogen activator receptor (uPAR) colocalise in human articular chodrocytes [<xref ref-type="bibr" rid="B65">65</xref>]. uPAR has an integral role in plasmin activation and thereby promotes catabolic events through initiation of a proteolytic cascade through which matrix-degrading enzymes described in IVD degeneration such as MMPs are activated [<xref ref-type="bibr" rid="B66">66</xref>]. Both could conceivably be pathways via which elevated caveolin-1 levels exert aspects of the senescent cellular phenotype observed in IVD degeneration.</p></sec><sec><title>Conclusion</title><p>This study has shown that caveolin-1 expression in human NP cells is linked to IVD degeneration and is associated with the senescent phenotype as depicted by increased expression of p16<sup>INK4a</sup>. Caveolin-1 expression was not linked to increasing chronological age, suggesting a role in accelerated degeneration which could be due to SIPS, rather than RS. Further work will elucidate the role of caveolin-1 in these related areas.</p></sec><sec><title>Abbreviations</title><p>ABI = Applied Biosystems (Warrington, UK); ADAMTS = a disintegrin and metalloprotease with thrombospondin motifs; AF = annulus fibrosus; AGE = advanced glycation endproduct; CML = carboxymethyl-lysine; Ct = cycle threshold; DMEM + F-12 = Dulbecco's modified Eagle's medium and Ham's F-12 nutrient medium; gDNA = genomic DNA; IHC = immunohistochemistry; IL = interleukin; IVD = intervertebral disc; LBP = low back pain; MMP = matrix metalloproteinase; NP = nucleus pulposus; PCR = polymerase chain reaction; PDAR = pre-developed assay reagent; PM = post mortem; qRT-PCR = quantitative real-time reverse transcription-polymerase chain reaction; RAGE = receptor for advanced glycation endproducts; RS = replicative senescence; SA-&#x003b2;-gal = senescence-associated &#x003b2;-galactosidase; SD = standard deviation; SEM = standard error of the mean; SIPS = stress-induced premature senescence; TBS = Tris-buffered saline; uPAR = urokinase plasminogen activator receptor.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>SKH participated in the design of the study, performed the majority of the laboratory work and analysis, and drafted the manuscript. CLM helped to secure funding, participated in the design of the study and the interpretation of data, and assisted in the preparation of the final manuscript. JAH conceived the study, secured funding, contributed to the design and coordination of the study, and participated in the interpretation of data and extensive preparation of the final manuscript. All authors read and approved the final manuscript.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>This work was funded by a grant from DISCS (Diagnostic Investigation of Spinal Conditions and Sciatica) and was undertaken in the Human Tissue Profiling Laboratories of the Tissue Injury and Repair research group.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Burton</surname><given-names>AK</given-names></name><name><surname>Balague</surname><given-names>F</given-names></name><name><surname>Cardon</surname><given-names>G</given-names></name><name><surname>Eriksen</surname><given-names>HR</given-names></name><name><surname>Henrotin</surname><given-names>Y</given-names></name><name><surname>Lahad</surname><given-names>A</given-names></name><name><surname>Leclerc</surname><given-names>A</given-names></name><name><surname>Muller</surname><given-names>G</given-names></name><name><surname>Beek</surname><given-names>AJ van der</given-names></name></person-group><article-title>Chapter 2. European guidelines for prevention in low back pain: November 2004</article-title><source>Eur Spine J</source><year>2006</year><volume>15</volume><issue>Suppl 2</issue><fpage>S136</fpage><lpage>168</lpage><pub-id pub-id-type="pmid">16550446</pub-id><pub-id pub-id-type="doi">10.1007/s00586-006-1070-3</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maniadakis</surname><given-names>N</given-names></name><name><surname>Gray</surname><given-names>A</given-names></name></person-group><article-title>The economic burden of back pain in the UK</article-title><source>Pain</source><year>2000</year><volume>84</volume><fpage>95</fpage><lpage>103</lpage><pub-id pub-id-type="pmid">10601677</pub-id><pub-id pub-id-type="doi">10.1016/S0304-3959(99)00187-6</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>CK</given-names></name><name><surname>Bolton</surname><given-names>JE</given-names></name><name><surname>Wood</surname><given-names>AR</given-names></name></person-group><article-title>A cross-sectional study correlating lumbar spine degeneration with disability and pain</article-title><source>Spine</source><year>2000</year><volume>25</volume><fpage>218</fpage><lpage>223</lpage><pub-id pub-id-type="pmid">10685487</pub-id><pub-id pub-id-type="doi">10.1097/00007632-200001150-00013</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luoma</surname><given-names>K</given-names></name><name><surname>Riihimaki</surname><given-names>H</given-names></name><name><surname>Luukkonen</surname><given-names>R</given-names></name><name><surname>Raininko</surname><given-names>R</given-names></name><name><surname>Viikari-Juntura</surname><given-names>E</given-names></name><name><surname>Lamminen</surname><given-names>A</given-names></name></person-group><article-title>Low back pain in relation to lumbar disc degeneration</article-title><source>Spine</source><year>2000</year><volume>25</volume><fpage>487</fpage><lpage>492</lpage><pub-id pub-id-type="pmid">10707396</pub-id><pub-id pub-id-type="doi">10.1097/00007632-200002150-00016</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roughley</surname><given-names>PJ</given-names></name></person-group><article-title>Biology of intervertebral disc aging and degeneration: involvement of the extracellular matrix</article-title><source>Spine</source><year>2004</year><volume>29</volume><fpage>2691</fpage><lpage>2699</lpage><pub-id pub-id-type="pmid">15564918</pub-id><pub-id pub-id-type="doi">10.1097/01.brs.0000146101.53784.b1</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>MA</given-names></name><name><surname>Roughley</surname><given-names>PJ</given-names></name></person-group><article-title>What is intervertebral disc degeneration, and what causes it?</article-title><source>Spine</source><year>2006</year><volume>31</volume><fpage>2151</fpage><lpage>2161</lpage><pub-id pub-id-type="pmid">16915105</pub-id><pub-id pub-id-type="doi">10.1097/01.brs.0000231761.73859.2c</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sambrook</surname><given-names>PN</given-names></name><name><surname>MacGregor</surname><given-names>AJ</given-names></name><name><surname>Spector</surname><given-names>TD</given-names></name></person-group><article-title>Genetic influences on cervical and lumbar disc degeneration: a magnetic resonance imaging study in twins</article-title><source>Arthritis Rheum</source><year>1999</year><volume>42</volume><fpage>366</fpage><lpage>372</lpage><pub-id pub-id-type="pmid">10025932</pub-id><pub-id pub-id-type="doi">10.1002/1529-0131(199902)42:2&#x0003c;366::AID-ANR20&#x0003e;3.0.CO;2-6</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>MacGregor</surname><given-names>AJ</given-names></name><name><surname>Andrew</surname><given-names>T</given-names></name><name><surname>Sambrook</surname><given-names>PN</given-names></name><name><surname>Spector</surname><given-names>TD</given-names></name></person-group><article-title>Structural, psychological, and genetic influences on low back and neck pain: a study of adult female twins</article-title><source>Arthritis Rheum</source><year>2004</year><volume>51</volume><fpage>160</fpage><lpage>167</lpage><pub-id pub-id-type="pmid">15077255</pub-id><pub-id pub-id-type="doi">10.1002/art.20236</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>JA</given-names></name><name><surname>Schmatz</surname><given-names>C</given-names></name><name><surname>Schultz</surname><given-names>AB</given-names></name></person-group><article-title>Lumbar disc degeneration: correlation with age, sex, and spine level in 600 autopsy specimens</article-title><source>Spine</source><year>1988</year><volume>13</volume><fpage>173</fpage><lpage>178</lpage><pub-id pub-id-type="pmid">3406837</pub-id><pub-id pub-id-type="doi">10.1097/00007632-198802000-00008</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boos</surname><given-names>N</given-names></name><name><surname>Weissbach</surname><given-names>S</given-names></name><name><surname>Rohrbach</surname><given-names>H</given-names></name><name><surname>Weiler</surname><given-names>C</given-names></name><name><surname>Spratt</surname><given-names>KF</given-names></name><name><surname>Nerlich</surname><given-names>AG</given-names></name></person-group><article-title>Classification of age-related changes in lumbar intervertebral discs: 2002 Volvo Award in basic science</article-title><source>Spine</source><year>2002</year><volume>27</volume><fpage>2631</fpage><lpage>2644</lpage><pub-id pub-id-type="pmid">12461389</pub-id><pub-id pub-id-type="doi">10.1097/00007632-200212010-00002</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>DG</given-names></name><name><surname>Tannoury</surname><given-names>C</given-names></name></person-group><article-title>Molecular pathogenic factors in symptomatic disc degeneration</article-title><source>Spine J</source><year>2005</year><volume>5</volume><issue>Suppl 6</issue><fpage>260S</fpage><lpage>266S</lpage><pub-id pub-id-type="pmid">16291122</pub-id><pub-id pub-id-type="doi">10.1016/j.spinee.2005.02.010</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Freemont</surname><given-names>AJ</given-names></name><name><surname>Watkins</surname><given-names>A</given-names></name><name><surname>Le Maitre</surname><given-names>C</given-names></name><name><surname>Jeziorska</surname><given-names>M</given-names></name><name><surname>Hoyland</surname><given-names>JA</given-names></name></person-group><article-title>Current understanding of cellular and molecular events in intervertebral disc degeneration: implications for therapy</article-title><source>J Pathol</source><year>2002</year><volume>196</volume><fpage>374</fpage><lpage>379</lpage><pub-id pub-id-type="pmid">11920731</pub-id><pub-id pub-id-type="doi">10.1002/path.1050</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Minamino</surname><given-names>T</given-names></name><name><surname>Komuro</surname><given-names>I</given-names></name></person-group><article-title>Vascular cell senescence: contribution to atherosclerosis</article-title><source>Circ Res</source><year>2007</year><volume>100</volume><fpage>15</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">17204661</pub-id><pub-id pub-id-type="doi">10.1161/01.RES.0000256837.40544.4a</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Price</surname><given-names>JS</given-names></name><name><surname>Waters</surname><given-names>JG</given-names></name><name><surname>Darrah</surname><given-names>C</given-names></name><name><surname>Pennington</surname><given-names>C</given-names></name><name><surname>Edwards</surname><given-names>DR</given-names></name><name><surname>Donell</surname><given-names>ST</given-names></name><name><surname>Clark</surname><given-names>IM</given-names></name></person-group><article-title>The role of chondrocyte senescence in osteoarthritis</article-title><source>Aging Cell</source><year>2002</year><volume>1</volume><fpage>57</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">12882354</pub-id><pub-id pub-id-type="doi">10.1046/j.1474-9728.2002.00008.x</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>JA</given-names></name><name><surname>Buckwalter</surname><given-names>JA</given-names></name></person-group><article-title>Roles of articular cartilage aging and chondrocyte senescence in the pathogenesis of osteoarthritis</article-title><source>Iowa Orthop J</source><year>2001</year><volume>21</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">11813939</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>S</given-names></name><name><surname>Evans</surname><given-names>EH</given-names></name><name><surname>Kletsas</surname><given-names>D</given-names></name><name><surname>Jaffray</surname><given-names>DC</given-names></name><name><surname>Eisenstein</surname><given-names>SM</given-names></name></person-group><article-title>Senescence in human intervertebral discs</article-title><source>Eur Spine J</source><year>2006</year><volume>15</volume><issue>Suppl 15</issue><fpage>312</fpage><lpage>316</lpage><pub-id pub-id-type="pmid">16773379</pub-id><pub-id pub-id-type="doi">10.1007/s00586-006-0126-8</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gruber</surname><given-names>HE</given-names></name><name><surname>Ingram</surname><given-names>JA</given-names></name><name><surname>Norton</surname><given-names>HJ</given-names></name><name><surname>Hanley</surname><given-names>EN</given-names><suffix>Jr</suffix></name></person-group><article-title>Senescence in cells of the aging and degenerating intervertebral disc: immunolocalization of senescence-associated beta-galactosidase in human and sand rat discs</article-title><source>Spine</source><year>2007</year><volume>32</volume><fpage>321</fpage><lpage>327</lpage><pub-id pub-id-type="pmid">17268263</pub-id><pub-id pub-id-type="doi">10.1097/01.brs.0000253960.57051.de</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Le Maitre</surname><given-names>CL</given-names></name><name><surname>Freemont</surname><given-names>AJ</given-names></name><name><surname>Hoyland</surname><given-names>JA</given-names></name></person-group><article-title>Accelerated cellular senescence in degenerate intervertebral discs: a possible role in the pathogenesis of intervertebral disc degeneration</article-title><source>Arthritis Res Ther</source><year>2007</year><volume>9</volume><fpage>R45</fpage><pub-id pub-id-type="pmid">17498290</pub-id><pub-id pub-id-type="doi">10.1186/ar2198</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>SM</given-names></name><name><surname>Shan</surname><given-names>ZZ</given-names></name><name><surname>Nakamura</surname><given-names>H</given-names></name><name><surname>Masuko-Hongo</surname><given-names>K</given-names></name><name><surname>Kato</surname><given-names>T</given-names></name><name><surname>Nishioka</surname><given-names>K</given-names></name><name><surname>Yudoh</surname><given-names>K</given-names></name></person-group><article-title>Catabolic stress induces features of chondrocyte senescence through overexpression of caveolin 1: possible involvement of caveolin 1-induced down-regulation of articular chondrocytes in the pathogenesis of osteoarthritis</article-title><source>Arthritis Rheum</source><year>2006</year><volume>54</volume><fpage>818</fpage><lpage>831</lpage><pub-id pub-id-type="pmid">16508959</pub-id><pub-id pub-id-type="doi">10.1002/art.21639</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Frippiat</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>QM</given-names></name><name><surname>Zdanov</surname><given-names>S</given-names></name><name><surname>Magalhaes</surname><given-names>JP</given-names></name><name><surname>Remacle</surname><given-names>J</given-names></name><name><surname>Toussaint</surname><given-names>O</given-names></name></person-group><article-title>Subcytotoxic H2O2 stress triggers a release of transforming growth factor-beta 1, which induces biomarkers of cellular senescence of human diploid fibroblasts</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>2531</fpage><lpage>2537</lpage><pub-id pub-id-type="pmid">11060295</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M006809200</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dumont</surname><given-names>P</given-names></name><name><surname>Balbeur</surname><given-names>L</given-names></name><name><surname>Remacle</surname><given-names>J</given-names></name><name><surname>Toussaint</surname><given-names>O</given-names></name></person-group><article-title>Appearance of biomarkers of <italic>in vitro </italic>ageing after successive stimulation of WI-38 fibroblasts with IL-1alpha and TNF-alpha: senescence associated beta-galactosidase activity and morphotype transition</article-title><source>J Anat</source><year>2000</year><volume>197</volume><issue>Pt 4</issue><fpage>529</fpage><lpage>537</lpage><pub-id pub-id-type="pmid">11197525</pub-id><pub-id pub-id-type="doi">10.1046/j.1469-7580.2000.19740529.x</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dumont</surname><given-names>P</given-names></name><name><surname>Burton</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>QM</given-names></name><name><surname>Gonos</surname><given-names>ES</given-names></name><name><surname>Frippiat</surname><given-names>C</given-names></name><name><surname>Mazarati</surname><given-names>JB</given-names></name><name><surname>Eliaers</surname><given-names>F</given-names></name><name><surname>Remacle</surname><given-names>J</given-names></name><name><surname>Toussaint</surname><given-names>O</given-names></name></person-group><article-title>Induction of replicative senescence biomarkers by sublethal oxidative stresses in normal human fibroblast</article-title><source>Free Radic Biol Med</source><year>2000</year><volume>28</volume><fpage>361</fpage><lpage>373</lpage><pub-id pub-id-type="pmid">10699747</pub-id><pub-id pub-id-type="doi">10.1016/S0891-5849(99)00249-X</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mendez</surname><given-names>MV</given-names></name><name><surname>Raffetto</surname><given-names>JD</given-names></name><name><surname>Phillips</surname><given-names>T</given-names></name><name><surname>Menzoian</surname><given-names>JO</given-names></name><name><surname>Park</surname><given-names>HY</given-names></name></person-group><article-title>The proliferative capacity of neonatal skin fibroblasts is reduced after exposure to venous ulcer wound fluid: a potential mechanism for senescence in venous ulcers</article-title><source>J Vasc Surg</source><year>1999</year><volume>30</volume><fpage>734</fpage><lpage>743</lpage><pub-id pub-id-type="pmid">10514213</pub-id><pub-id pub-id-type="doi">10.1016/S0741-5214(99)70113-8</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Ames</surname><given-names>BN</given-names></name></person-group><article-title>Senescence-like growth arrest induced by hydrogen peroxide in human diploid fibroblast F65 cells</article-title><source>Proc Natl Acad Sci USA</source><year>1994</year><volume>91</volume><fpage>4130</fpage><lpage>4134</lpage><pub-id pub-id-type="pmid">8183882</pub-id><pub-id pub-id-type="doi">10.1073/pnas.91.10.4130</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Parton</surname><given-names>RG</given-names></name><name><surname>Simons</surname><given-names>K</given-names></name></person-group><article-title>The multiple faces of caveolae</article-title><source>Nat Rev Mol Cell Biol</source><year>2007</year><volume>8</volume><fpage>185</fpage><lpage>194</lpage><pub-id pub-id-type="pmid">17318224</pub-id><pub-id pub-id-type="doi">10.1038/nrm2122</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smart</surname><given-names>EJ</given-names></name><name><surname>Graf</surname><given-names>GA</given-names></name><name><surname>McNiven</surname><given-names>MA</given-names></name><name><surname>Sessa</surname><given-names>WC</given-names></name><name><surname>Engelman</surname><given-names>JA</given-names></name><name><surname>Scherer</surname><given-names>PE</given-names></name><name><surname>Okamoto</surname><given-names>T</given-names></name><name><surname>Lisanti</surname><given-names>MP</given-names></name></person-group><article-title>Caveolins, liquid-ordered domains, and signal transduction</article-title><source>Mol Cell Biol</source><year>1999</year><volume>19</volume><fpage>7289</fpage><lpage>7304</lpage><pub-id pub-id-type="pmid">10523618</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>P</given-names></name><name><surname>Rudick</surname><given-names>M</given-names></name><name><surname>Anderson</surname><given-names>RG</given-names></name></person-group><article-title>Multiple functions of caveolin-1</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>41295</fpage><lpage>41298</lpage><pub-id pub-id-type="pmid">12189159</pub-id><pub-id pub-id-type="doi">10.1074/jbc.R200020200</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Okamoto</surname><given-names>T</given-names></name><name><surname>Schlegel</surname><given-names>A</given-names></name><name><surname>Scherer</surname><given-names>PE</given-names></name><name><surname>Lisanti</surname><given-names>MP</given-names></name></person-group><article-title>Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane</article-title><source>J Biol Chem</source><year>1998</year><volume>273</volume><fpage>5419</fpage><lpage>5422</lpage><pub-id pub-id-type="pmid">9488658</pub-id><pub-id pub-id-type="doi">10.1074/jbc.273.10.5419</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>WY</given-names></name><name><surname>Park</surname><given-names>JS</given-names></name><name><surname>Cho</surname><given-names>KA</given-names></name><name><surname>Kim</surname><given-names>DI</given-names></name><name><surname>Ko</surname><given-names>YG</given-names></name><name><surname>Seo</surname><given-names>JS</given-names></name><name><surname>Park</surname><given-names>SC</given-names></name></person-group><article-title>Up-regulation of caveolin attenuates epidermal growth factor signaling in senescent cells</article-title><source>J Biol Chem</source><year>2000</year><volume>275</volume><fpage>20847</fpage><lpage>20852</lpage><pub-id pub-id-type="pmid">10781609</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M908162199</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wheaton</surname><given-names>K</given-names></name><name><surname>Sampsel</surname><given-names>K</given-names></name><name><surname>Boisvert</surname><given-names>FM</given-names></name><name><surname>Davy</surname><given-names>A</given-names></name><name><surname>Robbins</surname><given-names>S</given-names></name><name><surname>Riabowol</surname><given-names>K</given-names></name></person-group><article-title>Loss of functional caveolae during senescence of human fibroblasts</article-title><source>J Cell Physiol</source><year>2001</year><volume>187</volume><fpage>226</fpage><lpage>235</lpage><pub-id pub-id-type="pmid">11268002</pub-id><pub-id pub-id-type="doi">10.1002/jcp.1071</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Volonte</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Lisanti</surname><given-names>MP</given-names></name><name><surname>Galbiati</surname><given-names>F</given-names></name></person-group><article-title>Expression of caveolin-1 induces premature cellular senescence in primary cultures of murine fibroblasts</article-title><source>Mol Biol Cell</source><year>2002</year><volume>13</volume><fpage>2502</fpage><lpage>2517</lpage><pub-id pub-id-type="pmid">12134086</pub-id><pub-id pub-id-type="doi">10.1091/mbc.01-11-0529</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Linge</surname><given-names>A</given-names></name><name><surname>Weinhold</surname><given-names>K</given-names></name><name><surname>Blasche</surname><given-names>R</given-names></name><name><surname>Kasper</surname><given-names>M</given-names></name><name><surname>Barth</surname><given-names>K</given-names></name></person-group><article-title>Downregulation of caveolin-1 affects bleomycin-induced growth arrest and cellular senescence in A549 cells</article-title><source>Int J Biochem Cell Biol</source><year>2007</year><volume>39</volume><fpage>1964</fpage><lpage>1974</lpage><pub-id pub-id-type="pmid">17662641</pub-id><pub-id pub-id-type="doi">10.1016/j.biocel.2007.05.018</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Voghel</surname><given-names>G</given-names></name><name><surname>Thorin-Trescases</surname><given-names>N</given-names></name><name><surname>Farhat</surname><given-names>N</given-names></name><name><surname>Nguyen</surname><given-names>A</given-names></name><name><surname>Villeneuve</surname><given-names>L</given-names></name><name><surname>Mamarbachi</surname><given-names>AM</given-names></name><name><surname>Fortier</surname><given-names>A</given-names></name><name><surname>Perrault</surname><given-names>LP</given-names></name><name><surname>Carrier</surname><given-names>M</given-names></name><name><surname>Thorin</surname><given-names>E</given-names></name></person-group><article-title>Cellular senescence in endothelial cells from atherosclerotic patients is accelerated by oxidative stress associated with cardiovascular risk factors</article-title><source>Mech Ageing Dev</source><year>2007</year><volume>128</volume><fpage>662</fpage><lpage>671</lpage><pub-id pub-id-type="pmid">18022214</pub-id><pub-id pub-id-type="doi">10.1016/j.mad.2007.09.006</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nerlich</surname><given-names>AG</given-names></name><name><surname>Bachmeier</surname><given-names>BE</given-names></name><name><surname>Schleicher</surname><given-names>E</given-names></name><name><surname>Rohrbach</surname><given-names>H</given-names></name><name><surname>Paesold</surname><given-names>G</given-names></name><name><surname>Boos</surname><given-names>N</given-names></name></person-group><article-title>Immunomorphological analysis of RAGE receptor expression and NF-kappaB activation in tissue samples from normal and degenerated intervertebral discs of various ages</article-title><source>Ann N Y Acad Sci</source><year>2007</year><volume>1096</volume><fpage>239</fpage><lpage>248</lpage><pub-id pub-id-type="pmid">17405935</pub-id><pub-id pub-id-type="doi">10.1196/annals.1397.090</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nerlich</surname><given-names>AG</given-names></name><name><surname>Schleicher</surname><given-names>ED</given-names></name><name><surname>Boos</surname><given-names>N</given-names></name></person-group><article-title>1997 Volvo Award winner in basic science studies. Immunohistologic markers for age-related changes of human lumbar intervertebral discs</article-title><source>Spine</source><year>1997</year><volume>22</volume><fpage>2781</fpage><lpage>2795</lpage><pub-id pub-id-type="pmid">9431614</pub-id><pub-id pub-id-type="doi">10.1097/00007632-199712150-00001</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schleicher</surname><given-names>ED</given-names></name><name><surname>Wagner</surname><given-names>E</given-names></name><name><surname>Nerlich</surname><given-names>AG</given-names></name></person-group><article-title>Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging</article-title><source>J Clin Invest</source><year>1997</year><volume>99</volume><fpage>457</fpage><lpage>468</lpage><pub-id pub-id-type="pmid">9022079</pub-id><pub-id pub-id-type="doi">10.1172/JCI119180</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Le Maitre</surname><given-names>CL</given-names></name><name><surname>Freemont</surname><given-names>AJ</given-names></name><name><surname>Hoyland</surname><given-names>JA</given-names></name></person-group><article-title>The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration</article-title><source>Arthritis Res Ther</source><year>2005</year><volume>7</volume><fpage>R732</fpage><lpage>745</lpage><pub-id pub-id-type="pmid">15987475</pub-id><pub-id pub-id-type="doi">10.1186/ar1732</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Le Maitre</surname><given-names>CL</given-names></name><name><surname>Hoyland</surname><given-names>JA</given-names></name><name><surname>Freemont</surname><given-names>AJ</given-names></name></person-group><article-title>Catabolic cytokine expression in degenerate and herniated human intervertebral discs: IL-1beta and TNFalpha expression profile</article-title><source>Arthritis Res Ther</source><year>2007</year><volume>9</volume><fpage>R77</fpage><pub-id pub-id-type="pmid">17688691</pub-id><pub-id pub-id-type="doi">10.1186/ar2275</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sive</surname><given-names>JI</given-names></name><name><surname>Baird</surname><given-names>P</given-names></name><name><surname>Jeziorsk</surname><given-names>M</given-names></name><name><surname>Watkins</surname><given-names>A</given-names></name><name><surname>Hoyland</surname><given-names>JA</given-names></name><name><surname>Freemont</surname><given-names>AJ</given-names></name></person-group><article-title>Expression of chondrocyte markers by cells of normal and degenerate intervertebral discs</article-title><source>Mol Pathol</source><year>2002</year><volume>55</volume><fpage>91</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">11950957</pub-id><pub-id pub-id-type="doi">10.1136/mp.55.2.91</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Le Maitre</surname><given-names>CL</given-names></name><name><surname>Freemont</surname><given-names>AJ</given-names></name><name><surname>Hoyland</surname><given-names>JA</given-names></name></person-group><article-title>Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc</article-title><source>J Pathol</source><year>2004</year><volume>204</volume><fpage>47</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">15307137</pub-id><pub-id pub-id-type="doi">10.1002/path.1608</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Toussaint</surname><given-names>O</given-names></name><name><surname>Dumont</surname><given-names>P</given-names></name><name><surname>Dierick</surname><given-names>JF</given-names></name><name><surname>Pascal</surname><given-names>T</given-names></name><name><surname>Frippiat</surname><given-names>C</given-names></name><name><surname>Chainiaux</surname><given-names>F</given-names></name><name><surname>Sluse</surname><given-names>F</given-names></name><name><surname>Eliaers</surname><given-names>F</given-names></name><name><surname>Remacle</surname><given-names>J</given-names></name></person-group><article-title>Stress-induced premature senescence. Essence of life, evolution, stress, and aging</article-title><source>Ann N Y Acad Sci</source><year>2000</year><volume>908</volume><fpage>85</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">10911950</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Campisi</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Lim</surname><given-names>CS</given-names></name><name><surname>Rubio</surname><given-names>M</given-names></name></person-group><article-title>Cellular senescence, cancer and aging: the telomere connection</article-title><source>Exp Gerontol</source><year>2001</year><volume>36</volume><fpage>1619</fpage><lpage>1637</lpage><pub-id pub-id-type="pmid">11672984</pub-id><pub-id pub-id-type="doi">10.1016/S0531-5565(01)00160-7</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>JA</given-names></name><name><surname>Buckwalter</surname><given-names>JA</given-names></name></person-group><article-title>Aging, articular cartilage chondrocyte senescence and osteoarthritis</article-title><source>Biogerontology</source><year>2002</year><volume>3</volume><fpage>257</fpage><lpage>264</lpage><pub-id pub-id-type="pmid">12237562</pub-id><pub-id pub-id-type="doi">10.1023/A:1020185404126</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hayflick</surname><given-names>L</given-names></name></person-group><article-title>The limited <italic>in vitro </italic>lifetime of human diploid cell strains</article-title><source>Exp Cell Res</source><year>1965</year><volume>37</volume><fpage>614</fpage><lpage>636</lpage><pub-id pub-id-type="pmid">14315085</pub-id><pub-id pub-id-type="doi">10.1016/0014-4827(65)90211-9</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>CW</given-names></name><name><surname>Bump</surname><given-names>EA</given-names></name><name><surname>Kim</surname><given-names>JS</given-names></name><name><surname>Janigro</surname><given-names>D</given-names></name><name><surname>Mayberg</surname><given-names>MR</given-names></name></person-group><article-title>Induction of a senescence-like phenotype in bovine aortic endothelial cells by ionizing radiation</article-title><source>Radiat Res</source><year>2001</year><volume>156</volume><fpage>232</fpage><lpage>240</lpage><pub-id pub-id-type="pmid">11500132</pub-id><pub-id pub-id-type="doi">10.1667/0033-7587(2001)156[0232:IOASLP]2.0.CO;2</pub-id></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chainiaux</surname><given-names>F</given-names></name><name><surname>Magalhaes</surname><given-names>JP</given-names></name><name><surname>Eliaers</surname><given-names>F</given-names></name><name><surname>Remacle</surname><given-names>J</given-names></name><name><surname>Toussaint</surname><given-names>O</given-names></name></person-group><article-title>UVB-induced premature senescence of human diploid skin fibroblasts</article-title><source>Int J Biochem Cell Biol</source><year>2002</year><volume>34</volume><fpage>1331</fpage><lpage>1339</lpage><pub-id pub-id-type="pmid">12200029</pub-id><pub-id pub-id-type="doi">10.1016/S1357-2725(02)00022-5</pub-id></citation></ref><ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Medrano</surname><given-names>EE</given-names></name><name><surname>Im</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Abdel-Malek</surname><given-names>ZA</given-names></name></person-group><article-title>Ultraviolet B light induces G1 arrest in human melanocytes by prolonged inhibition of retinoblastoma protein phosphorylation associated with long-term expression of the p21Waf-1/SDI-1/Cip-1 protein</article-title><source>Cancer Res</source><year>1995</year><volume>55</volume><fpage>4047</fpage><lpage>4052</lpage><pub-id pub-id-type="pmid">7664278</pub-id></citation></ref><ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Wong</surname><given-names>SC</given-names></name><name><surname>Pan</surname><given-names>J</given-names></name><name><surname>Tsao</surname><given-names>SW</given-names></name><name><surname>Fung</surname><given-names>KH</given-names></name><name><surname>Kwong</surname><given-names>DL</given-names></name><name><surname>Sham</surname><given-names>JS</given-names></name><name><surname>Nicholls</surname><given-names>JM</given-names></name></person-group><article-title>Evidence of cisplatin-induced senescent-like growth arrest in nasopharyngeal carcinoma cells</article-title><source>Cancer Res</source><year>1998</year><volume>58</volume><fpage>5019</fpage><lpage>5022</lpage><pub-id pub-id-type="pmid">9823301</pub-id></citation></ref><ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rodemann</surname><given-names>HP</given-names></name></person-group><article-title>Differential degradation of intracellular proteins in human skin fibroblasts of mitotic and mitomycin-C (MMC)-induced postmitotic differentiation states <italic>in vitro</italic></article-title><source>Differentiation</source><year>1989</year><volume>42</volume><fpage>37</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">2620784</pub-id><pub-id pub-id-type="doi">10.1111/j.1432-0436.1989.tb00605.x</pub-id></citation></ref><ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Robles</surname><given-names>SJ</given-names></name><name><surname>Buehler</surname><given-names>PW</given-names></name><name><surname>Negrusz</surname><given-names>A</given-names></name><name><surname>Adami</surname><given-names>GR</given-names></name></person-group><article-title>Permanent cell cycle arrest in asynchronously proliferating normal human fibroblasts treated with doxorubicin or etoposide but not camptothecin</article-title><source>Biochem Pharmacol</source><year>1999</year><volume>58</volume><fpage>675</fpage><lpage>685</lpage><pub-id pub-id-type="pmid">10413306</pub-id><pub-id pub-id-type="doi">10.1016/S0006-2952(99)00127-6</pub-id></citation></ref><ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Serrano</surname><given-names>M</given-names></name><name><surname>Lin</surname><given-names>AW</given-names></name><name><surname>McCurrach</surname><given-names>ME</given-names></name><name><surname>Beach</surname><given-names>D</given-names></name><name><surname>Lowe</surname><given-names>SW</given-names></name></person-group><article-title>Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a</article-title><source>Cell</source><year>1997</year><volume>88</volume><fpage>593</fpage><lpage>602</lpage><pub-id pub-id-type="pmid">9054499</pub-id><pub-id pub-id-type="doi">10.1016/S0092-8674(00)81902-9</pub-id></citation></ref><ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>KA</given-names></name><name><surname>Park</surname><given-names>SC</given-names></name></person-group><article-title>Caveolin-1 as a prime modulator of aging: a new modality for phenotypic restoration?</article-title><source>Mech Ageing Dev</source><year>2005</year><volume>126</volume><fpage>105</fpage><lpage>110</lpage><pub-id pub-id-type="pmid">15610768</pub-id><pub-id pub-id-type="doi">10.1016/j.mad.2004.09.029</pub-id></citation></ref><ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sherr</surname><given-names>CJ</given-names></name><name><surname>Roberts</surname><given-names>JM</given-names></name></person-group><article-title>CDK inhibitors: positive and negative regulators of G1-phase progression</article-title><source>Genes Dev</source><year>1999</year><volume>13</volume><fpage>1501</fpage><lpage>1512</lpage><pub-id pub-id-type="pmid">10385618</pub-id><pub-id pub-id-type="doi">10.1101/gad.13.12.1501</pub-id></citation></ref><ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huschtscha</surname><given-names>LI</given-names></name><name><surname>Reddel</surname><given-names>RR</given-names></name></person-group><article-title>p16(INK4a) and the control of cellular proliferative life span</article-title><source>Carcinogenesis</source><year>1999</year><volume>20</volume><fpage>921</fpage><lpage>926</lpage><pub-id pub-id-type="pmid">10357768</pub-id><pub-id pub-id-type="doi">10.1093/carcin/20.6.921</pub-id></citation></ref><ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Satyanarayana</surname><given-names>A</given-names></name><name><surname>Rudolph</surname><given-names>KL</given-names></name></person-group><article-title>p16 and ARF: activation of teenage proteins in old age</article-title><source>J Clin Invest</source><year>2004</year><volume>114</volume><fpage>1237</fpage><lpage>1240</lpage><pub-id pub-id-type="pmid">15520854</pub-id></citation></ref><ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beausejour</surname><given-names>CM</given-names></name><name><surname>Krtolica</surname><given-names>A</given-names></name><name><surname>Galimi</surname><given-names>F</given-names></name><name><surname>Narita</surname><given-names>M</given-names></name><name><surname>Lowe</surname><given-names>SW</given-names></name><name><surname>Yaswen</surname><given-names>P</given-names></name><name><surname>Campisi</surname><given-names>J</given-names></name></person-group><article-title>Reversal of human cellular senescence: roles of the p53 and p16 pathways</article-title><source>Embo J</source><year>2003</year><volume>22</volume><fpage>4212</fpage><lpage>4222</lpage><pub-id pub-id-type="pmid">12912919</pub-id><pub-id pub-id-type="doi">10.1093/emboj/cdg417</pub-id></citation></ref><ref id="B57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krishnamurthy</surname><given-names>J</given-names></name><name><surname>Torrice</surname><given-names>C</given-names></name><name><surname>Ramsey</surname><given-names>MR</given-names></name><name><surname>Kovalev</surname><given-names>GI</given-names></name><name><surname>Al-Regaiey</surname><given-names>K</given-names></name><name><surname>Su</surname><given-names>L</given-names></name><name><surname>Sharpless</surname><given-names>NE</given-names></name></person-group><article-title>Ink4a/Arf expression is a biomarker of aging</article-title><source>J Clin Invest</source><year>2004</year><volume>114</volume><fpage>1299</fpage><lpage>1307</lpage><pub-id pub-id-type="pmid">15520862</pub-id></citation></ref><ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>HW</given-names></name><name><surname>Lou</surname><given-names>SQ</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name></person-group><article-title>Recovery of function in osteoarthritic chondrocytes induced by p16INK4a-specific siRNA <italic>in vitro</italic></article-title><source>Rheumatology (Oxford)</source><year>2004</year><volume>43</volume><fpage>555</fpage><lpage>568</lpage><pub-id pub-id-type="pmid">15026580</pub-id><pub-id pub-id-type="doi">10.1093/rheumatology/keh127</pub-id></citation></ref><ref id="B59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Robles</surname><given-names>SJ</given-names></name><name><surname>Adami</surname><given-names>GR</given-names></name></person-group><article-title>Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts</article-title><source>Oncogene</source><year>1998</year><volume>16</volume><fpage>1113</fpage><lpage>1123</lpage><pub-id pub-id-type="pmid">9528853</pub-id><pub-id pub-id-type="doi">10.1038/sj.onc.1201862</pub-id></citation></ref><ref id="B60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>JI</given-names></name><name><surname>Jeong</surname><given-names>JS</given-names></name><name><surname>Han</surname><given-names>JY</given-names></name><name><surname>Kim</surname><given-names>DI</given-names></name><name><surname>Gao</surname><given-names>YH</given-names></name><name><surname>Park</surname><given-names>SC</given-names></name><name><surname>Rodgers</surname><given-names>GP</given-names></name><name><surname>Kim</surname><given-names>IH</given-names></name></person-group><article-title>Hydroxyurea induces a senescence-like change of K562 human erythroleukemia cell</article-title><source>J Cancer Res Clin Oncol</source><year>2000</year><volume>126</volume><fpage>455</fpage><lpage>460</lpage><pub-id pub-id-type="pmid">10961388</pub-id><pub-id pub-id-type="doi">10.1007/s004320050013</pub-id></citation></ref><ref id="B61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Le Maitre</surname><given-names>CL</given-names></name><name><surname>Hoyland</surname><given-names>JA</given-names></name><name><surname>Freemont</surname><given-names>AJ</given-names></name></person-group><article-title>Interleukin-1 receptor antagonist delivered directly and by gene therapy inhibits matrix degradation in the intact degenerate human intervertebral disc: an <italic>in situ </italic>zymographic and gene therapy study</article-title><source>Arthritis Res Ther</source><year>2007</year><volume>9</volume><fpage>R83</fpage><pub-id pub-id-type="pmid">17760968</pub-id><pub-id pub-id-type="doi">10.1186/ar2282</pub-id></citation></ref><ref id="B62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Le Maitre</surname><given-names>CL</given-names></name><name><surname>Pockert</surname><given-names>A</given-names></name><name><surname>Buttle</surname><given-names>DJ</given-names></name><name><surname>Freemont</surname><given-names>AJ</given-names></name><name><surname>Hoyland</surname><given-names>JA</given-names></name></person-group><article-title>Matrix synthesis and degradation in human intervertebral disc degeneration</article-title><source>Biochem Soc Trans</source><year>2007</year><volume>35</volume><fpage>652</fpage><lpage>655</lpage><pub-id pub-id-type="pmid">17635113</pub-id><pub-id pub-id-type="doi">10.1042/BST0350652</pub-id></citation></ref><ref id="B63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lisanti</surname><given-names>MP</given-names></name><name><surname>Scherer</surname><given-names>PE</given-names></name><name><surname>Vidugiriene</surname><given-names>J</given-names></name><name><surname>Tang</surname><given-names>Z</given-names></name><name><surname>Hermanowski-Vosatka</surname><given-names>A</given-names></name><name><surname>Tu</surname><given-names>YH</given-names></name><name><surname>Cook</surname><given-names>RF</given-names></name><name><surname>Sargiacomo</surname><given-names>M</given-names></name></person-group><article-title>Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease</article-title><source>J Cell Biol</source><year>1994</year><volume>126</volume><fpage>111</fpage><lpage>126</lpage><pub-id pub-id-type="pmid">7517942</pub-id><pub-id pub-id-type="doi">10.1083/jcb.126.1.111</pub-id></citation></ref><ref id="B64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kislinger</surname><given-names>T</given-names></name><name><surname>Fu</surname><given-names>C</given-names></name><name><surname>Huber</surname><given-names>B</given-names></name><name><surname>Qu</surname><given-names>W</given-names></name><name><surname>Taguchi</surname><given-names>A</given-names></name><name><surname>Du Yan</surname><given-names>S</given-names></name><name><surname>Hofmann</surname><given-names>M</given-names></name><name><surname>Yan</surname><given-names>SF</given-names></name><name><surname>Pischetsrieder</surname><given-names>M</given-names></name><name><surname>Stern</surname><given-names>D</given-names></name><name><surname>Schmidt</surname><given-names>AM</given-names></name></person-group><article-title>N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression</article-title><source>J Biol Chem</source><year>1999</year><volume>274</volume><fpage>31740</fpage><lpage>31749</lpage><pub-id pub-id-type="pmid">10531386</pub-id><pub-id pub-id-type="doi">10.1074/jbc.274.44.31740</pub-id></citation></ref><ref id="B65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schwab</surname><given-names>W</given-names></name><name><surname>Gavlik</surname><given-names>JM</given-names></name><name><surname>Beichler</surname><given-names>T</given-names></name><name><surname>Funk</surname><given-names>RH</given-names></name><name><surname>Albrecht</surname><given-names>S</given-names></name><name><surname>Magdolen</surname><given-names>V</given-names></name><name><surname>Luther</surname><given-names>T</given-names></name><name><surname>Kasper</surname><given-names>M</given-names></name><name><surname>Shakibaei</surname><given-names>M</given-names></name></person-group><article-title>Expression of the urokinase-type plasminogen activator receptor in human articular chondrocytes: association with caveolin and beta 1-integrin</article-title><source>Histochem Cell Biol</source><year>2001</year><volume>115</volume><fpage>317</fpage><lpage>323</lpage><pub-id pub-id-type="pmid">11405060</pub-id></citation></ref><ref id="B66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nicholl</surname><given-names>SM</given-names></name><name><surname>Roztocil</surname><given-names>E</given-names></name><name><surname>Davies</surname><given-names>MG</given-names></name></person-group><article-title>Plasminogen activator system and vascular disease</article-title><source>Curr Vasc Pharmacol</source><year>2006</year><volume>4</volume><fpage>101</fpage><lpage>116</lpage><pub-id pub-id-type="pmid">16611153</pub-id><pub-id pub-id-type="doi">10.2174/157016106776359880</pub-id></citation></ref></ref-list></back></article> 